臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| Total items :2826208
	Visitors : 31897744 Online Users : 1347 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library

Scope

Adv. Search

Login

Administrator

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"j nne p a"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 1-10 of 18 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-08-10T02:37:38Z	Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients with EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial	Zhou C.; Ramalingam S.S.; Kim T.M.; Kim S.-W.; CHIH-HSIN YANG; Riely G.J.; Mekhail T.; Nguyen D.; Garcia Campelo M.R.; Felip E.; Vincent S.; Jin S.; Griffin C.; Bunn V.; Lin J.; Lin H.M.; Mehta M.; J?nne P.A.
臺大學術典藏	2022-08-10T02:37:37Z	Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer	J?nne P.A.; Baik C.; Su W.-C.; Johnson M.L.; Hayashi H.; Nishio M.; Kim D.-W.; Koczywas M.; Gold K.A.; Steuer C.E.; Murakami H.; CHIH-HSIN YANG; Kim S.-W.; Vigliotti M.; Shi R.; Qi Z.; Qiu Y.; Zhao L.; Sternberg D.; Yu C.; Yu H.A.
臺大學術典藏	2022-06-27T06:59:36Z	Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study	Park K.; J?nne P.A.; Kim D.-W.; Han J.-Y.; Wu M.-F.; Lee J.-S.; Kang J.-H.; Lee D.H.; Cho B.C.; CHONG-JEN YU; Pang Y.K.; Felip E.; Kim H.; Baek E.; Noh Y.S.
臺大學術典藏	2021-05-02T03:29:22Z	Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study	Park K.; J?nne P.A.; Kim D.-W.; Han J.-Y.; Wu M.-F.; Lee J.-S.; Kang J.-H.; Lee D.H.; Cho B.C.; CHONG-JEN YU; Pang Y.K.; Felip E.; Kim H.; Baek E.; Noh Y.S.
臺大學術典藏	2020-12-02T02:33:14Z	Final results of the large-scale multinational trial PROFILE 1005: Efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer	Blackhall F.; Ross Camidge D.; Shaw A.T.; Soria J.-C.; Solomon B.J.; Mok T.; Hirsh V.; J?Nne P.A.; Shi Y.; Pan-Chyr Yang; De Pas T.; Hida T.; De Castro Carpe?O J.; Lanzalone S.; Polli A.; Iyer S.; Reisman A.; Wilner K.D.; Kim D.-W.; Blackhall F.; PAN-CHYR YANG et al.
臺大學術典藏	2020-05-26T09:26:54Z	AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer	Ranson M.;Ghiorghiu S;Dickinson P.A;Brown K.H;Cantarini M;Frewer P;Kim J.-H;Felip E;Haggstrom D;Horn L;Su W.-C;Kim S.-W;Ahn M.-J;Ramalingam S.S;Ohe Y;Planchard D;Kim D.-W;Chih-Hsin Yang;J?nne P.A; Jänne P.A; Chih-Hsin CHIH-HSIN YANG; Kim D.-W; Planchard D; Ohe Y; Ramalingam S.S; Ahn M.-J; Kim S.-W; Su W.-C; Horn L; Haggstrom D; Felip E; Kim J.-H; Frewer P; Cantarini M; Brown K.H; Dickinson P.A; Ghiorghiu S; Ranson M.
臺大學術典藏	2020-05-26T09:26:46Z	LBA1_PR: Osimertinib as first-line treatment for EGFR mutation-positive advanced NSCLC: updated efficacy and safety results from two Phase I expansion cohorts	J?nne P.A.;Ohe Y;Nogami N;John T;Kim D.-W;Kurata T;Lee C.K;Chih-Hsin Yang;Ramalingam S; Ramalingam S; CHIH-HSIN YANG; Lee C.K; Kurata T; Kim D.-W; John T; Nogami N; Ohe Y; Jänne P.A.
臺大學術典藏	2020-05-26T09:26:45Z	LBA2_PR: Osimertinib (AZD9291) in pre-treated pts with T790M-positive advanced NSCLC: updated Phase 1 (P1) and pooled Phase 2 (P2) results	Mitsudomi T.;Cantarini M;J?nne P.A;Ramalingam S.S;Chih-Hsin Yang; CHIH-HSIN YANG; Ramalingam S.S; Jänne P.A; Cantarini M; Mitsudomi T.
臺大學術典藏	2020-05-26T09:26:44Z	Preclinical comparison of osimertinib with other EGFR-TKIs in EGFR-mutant NSCLC brain metastases models, and early evidence of clinical brain metastases activity	Box M; Johnström P; Varnäs K; Malmquist J; Thress K.S; Jänne P.A; Cross D.; Cross D.;J?nne P.A;Thress K.S;Malmquist J;Varn?s K;Johnstr?m P;Box M;Grist M;Hickey M;Jordan A;Pickup K;Cantarini M;Chih-Hsin Yang;Kim D.-W;Yang Z;Yates J.W.T;Ballard P; Ballard P; Yates J.W.T; Yang Z; Kim D.-W; CHIH-HSIN YANG; Cantarini M; Pickup K; Jordan A; Hickey M; Grist M
臺大學術典藏	2020-05-26T09:26:44Z	Association between plasma genotyping and outcomes of treatment with osimertinib (AZD9291) in advanced non-small-cell lung cancer	J?nne P.A.;Barrett J.C;Chih-Hsin Yang;Cantarini M;Paweletz C.P;Lawrance R;Alden R.S;Thress K.S;Oxnard G.R; Oxnard G.R; Thress K.S; Alden R.S; Lawrance R; Paweletz C.P; Cantarini M; CHIH-HSIN YANG; Barrett J.C; Jänne P.A.

Showing items 1-10 of 18 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page